397
Participants
Start Date
April 14, 2013
Primary Completion Date
May 12, 2014
Study Completion Date
January 9, 2019
Secukinumab (AIN457)
Secukinumab (AIN457)
Placebo
Placebo PFS for s.c. administration.
Novartis Investigative Site, Kogarah
Novartis Investigative Site, Leuven
Novartis Investigative Site, Malvern East
Novartis Investigative Site, Hasselt
Novartis Investigative Site, Genk
Novartis Investigative Site, Maroochydore
Novartis Investigative Site, Hobart
Novartis Investigative Site, Bangkok
Novartis Investigative Site, Berlin
Novartis Investigative Site, Syracuse
Novartis Investigative Site, Duncansville
Novartis Investigative Site, Hamburg
Novartis Investigative Site, Charlotte
Novartis Investigative Site, Asheville
Novartis Investigative Site, Columbia
Novartis Investigative Site, Charleston
Novartis Investigative Site, Greenville
Novartis Investigative Site, Aventura
Novartis Investigative Site, Tamarac
Novartis Investigative Site, Zephyrhills
Novartis Investigative Site, Tampa
Novartis Investigative Site, Sarasota
Novartis Investigative Site, Palm Harbor
Novartis Investigative Site, Zerbst
Novartis Investigative Site, Herne
Novartis Investigative Site, Aachen
Novartis Investigative Site, Pardubice
Novartis Investigative Site, Omaha
Novartis Investigative Site, Lincoln
Novartis Investigative Site, Oklahoma City
Novartis Investigative Site, Oklahoma City
Novartis Investigative Site, Mesquite
Novartis Investigative Site, League City
Novartis Investigative Site, Germering
Novartis Investigative Site, Peoria
Novartis Investigative Site, Erlangen
Novartis Investigative Site, Erlangen
Novartis Investigative Site, Würzburg
Novartis Investigative Site, Moscow
Novartis Investigative Site, Yaroslavl
Novartis Investigative Site, Petrozavodsk
Novartis Investigative Site, Saint Petersburg
Novartis Investigative Site, Sestroretsk
Novartis Investigative Site, Rostov-on-Don
Novartis Investigative Site, Kazan'
Novartis Investigative Site, Chelyabinsk
Novartis Investigative Site, Yekaterinburg
Novartis Investigative Site, Freehold
Novartis Investigative Site, Winnipeg
Novartis Investigative Site, Waterloo
Novartis Investigative Site, Pointe-Claire
Novartis Investigative Site, Québec
Novartis Investigative Site, Sainte-Foy
Novartis Investigative Site, Trois-Rivières
Novartis Investigative Site, Bruntál
Novartis Investigative Site, Prague
Novartis Investigative Site, Uherské Hradiště
Novartis Investigative Site, Lodz
Novartis Investigative Site, Poznan
Novartis Investigative Site, Poznan
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Warsaw
Novartis Investigative Site, Wroclaw
Novartis Investigative Site, Ponce
Novartis Investigative Site, London
Novartis Investigative Site, Salford
Novartis Investigative Site, Cannock
Novartis Investigative Site, Guildford
Novartis Investigative Site, Dudley
Novartis Investigative Site, Leeds
Novartis Investigative Site, Blackpool
Novartis Investigative Site, Cambridge
Novartis Investigative Site, Glasgow
Novartis Investigative Site, London
Novartis Investigative Site, London
Novartis Investigative Site, Southampton
Lead Sponsor
Novartis Pharmaceuticals
INDUSTRY